Quantum Biopharma (QNTM) Cash from Operations (2019 - 2026)
Quantum Biopharma (QNTM) posted Cash from Operations of 1668749.0 for Q1 2026, down 446.06% sequentially from 305598.0 in Q4 2025, and up 60.84% YoY from 1037551.85 in Q1 2025.
Quantum Biopharma (QNTM) Cash from Operations (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Cash from Operations for 7 years, with the latest figure at 1668749.0 in Q1 2026.
- Quarterly Cash from Operations rose 60.84% year-over-year to 1668749.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5644918.0 (up 38.4% YoY) and the FY2025 annual result came in at 8237012.0, down 19.79% from the prior year.
- Cash from Operations fell to 1668749.0 in Q1 2026 per QNTM's latest filing, from 305598.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 9398050.0 in Q2 2022 and troughed at 50340664.0 in Q4 2022.
- A 4-year average of 3470424.08 and a median of 1668749.0 in 2026 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations surged 63.85% in 2022, then sank 221.38% in 2025.
- Over 4 years, Cash from Operations stood at 50340664.0 in 2022, then soared by 98.34% to 835762.0 in 2024, then jumped by 63.43% to 305598.0 in 2025, then tumbled by 446.06% to 1668749.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1668749.0, 305598.0, and 1721476.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | -1.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.79 Mn |
| Jun 30, 2026 | -1.79 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | -305,598.00 |
| Dec 31, 2025 | -305,598.00 |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Dec 31, 2024 | -835,762.00 |
| Dec 31, 2024 | -835,762.00 |
| Sep 30, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -606,482.00 |
| Jun 30, 2024 | -606,482.00 |
| Mar 31, 2024 | -1.97 Mn |
| Mar 31, 2024 | -1.97 Mn |